NLS PHARMACEUTICS LTD's ticker is NLSPW and the CUSIP is H57830111. A total of 8 filers reported holding NLS PHARMACEUTICS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,600 | -1.7% | 500,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $53,500 | -28.7% | 500,000 | -0.0% | 0.00% | 0.0% |
| Q1 2023 | $75,000 | -48.3% | 500,001 | +0.0% | 0.00% | -66.7% |
| Q4 2022 | $145,000 | +16.0% | 500,000 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $125,000 | +108.3% | 500,000 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $60,000 | -68.4% | 500,000 | 0.0% | 0.00% | -75.0% |
| Q1 2022 | $190,000 | -24.0% | 500,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $250,000 | -39.5% | 500,000 | 0.0% | 0.00% | -42.9% |
| Q3 2021 | $413,000 | -8.6% | 500,000 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $452,000 | -4.8% | 500,000 | 0.0% | 0.01% | -27.3% |
| Q1 2021 | $475,000 | – | 500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 170,100 | $17,895 | 0.12% |
| Altium Capital Management LP | 200,000 | $21,040 | 0.01% |
| ARMISTICE CAPITAL, LLC | 500,000 | $52,600 | 0.00% |
| CLEAR STREET LLC | 8,600 | $1 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Hudson Bay Capital Management LP | 200,000 | $21,040 | 0.00% |